IO NewsWire

January 13, 2011 07:30 ET

(NASDAQ: UNIS) Completes Major Milestone With Construction of Its New Facility

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire.

NEW YORK, NY--(Marketwire - January 13, 2011) - Unilife Corp. (NASDAQ: UNIS) has completed their new 160,000 square foot (Sq. Ft.) global headquarters in York, Pennsylvania.

The new facility will be able to accommodate the production of 400 million syringes annually, with the capability of adding an additional 100,000 Sq. Ft. to increase production to nearly 1 billion syringes annually. Unilife will begin commercial sales at the new facility in Q2 2011, with a majority of its 170 person workforce operating from the York, Pennsylvania headquarters.

With the new facility and the recent transition from being an Australian entity to a US corporation, Unilife should see substantial growth from its partnership with Sanofi-Aventis, its current discussions with other pharmaceutical industry leaders, and its highly motivated and experienced management team.

For more information, please visit,

Other active stocks are Becton, Dickinson and Co (NYSE: BDX), Pfizer, Inc (NYSE: PFE) and Merck & Company (NYSE: MRK)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information